Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

6,626.00ZAc
3:38pm BST
Change (% chg)

-309.00 (-4.46%)
Prev Close
6,935.00
Open
6,980.00
Day's High
6,999.00
Day's Low
6,568.00
Volume
2,006,351
Avg. Vol
1,774,929
52-wk High
29,800.00
52-wk Low
6,466.00

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 1.04
Market Cap(Mil.): R40,930.01
Shares Outstanding(Mil.): 456.45
Dividend: 3.15
Yield (%): 3.51

Financials

  APNJ.J Industry Sector
P/E (TTM): 7.90 29.73 33.85
EPS (TTM): 11.35 -- --
ROI: 5.32 13.04 12.69
ROE: 10.73 14.12 17.13

South Africa's Aspen to pay 8 million pounds to NHS after UK probe

British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds to resolve concerns related to overpayment for a treatment.

14 Aug 2019

South Africa's Aspen to pay 8 million pounds to NHS after UK probe

British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve concerns related to overpayment for a treatment.

14 Aug 2019

UPDATE 1-South Africa's Aspen to pay 8 mln pounds to NHS after UK probe

Aug 14 British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve concerns related to overpayment for a treatment.

14 Aug 2019

South Africa's Aspen to pay 8 mln pounds to NHS after UK probe

Aug 14 British authorities said on Wednesday South Africa's Aspen Pharmacare Holdings Ltd has agreed to pay the National Health Service (NHS) 8 million pounds ($9.65 million) to resolve competition concerns related to a company's treatment.

14 Aug 2019

South African drugmaker Aspen terminates talks with potential European partner

JOHANNESBURG, July 5 South African drugmaker Aspen Pharmacare said on Friday it had terminated talks with a potential partner in Europe, after announcing in March a strategic review of its European and domestic commercial pharmaceuticals businesses.

05 Jul 2019

Deals of the day-Mergers and acquisitions

May 20 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

20 May 2019

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

20 May 2019

UPDATE 1-South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy the South African drugmaker's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

20 May 2019

South Africa's Aspen sells Australian prescription portfolio to Mylan

JOHANNESBURG, May 20 Aspen Pharmacare said on Monday that Mylan NV had exercised an option to buy Aspen's portfolio of prescription and over-the-counter products in Australia for 188 million Australian dollars ($130 million).

20 May 2019

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

08 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates